UBC Medicine researchers have created a topical CRISPR-based therapy that could offer a lasting cure for a range of skin disorders. Gene-editing tools like CRISPR have unlocked new treatments for… Read More
Quadruplet regimen demonstrated significantly deeper and more durable responses, higher MRD negativity and improved progression-free survival versus a standard of care Approval marks the twelfth indication for DARZALEX FASPRO® and… Read More
Construction is officially underway on the planned $1.7 billion, state-of-the-art public health laboratory that will transform New York’s ability to detect, prevent, and respond to emerging public health threats. Construction… Read More
MISSISSAUGA, ON – Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that on January 22, 2026, Health Canada has approved Gazyva® (obinutuzumab) for the treatment of adult patients with… Read More
Centre for Heart Lung Innovation Principal Investigator, Dr. Zachary Laksman, has co-founded MyTrials.ai, a platform that uses artificial intelligence (AI) to streamline clinical trial recruitment and support patients in making informed decisions… Read More
